Accessibility Menu
Athira Pharma Stock Quote

Athira Pharma (NASDAQ: ATHA)

$3.93
(-7.7%)
-0.33
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$3.93
Daily Change
(-7.7%) $0.33
Day's Range
$3.85 - $4.2
Previous Close
$3.93
Open
$4.2
Beta
1.38
Volume
35,340
Average Volume
28,507
Market Cap
15.5M
Market Cap / Employee
$3.93M
52wk Range
$2.2 - $8.26
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$15.44
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Athira Pharma Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ATHA-25.71%-97.97%-54.12%-98%
S&P+14.5%+93.32%+14.09%+102%

Athira Pharma Company Info

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.20M17.4%
Market Cap$11.91M-88.3%
Market Cap / Employee$0.46M0.0%
Employees26-61.2%
Net Income-$6.97M74.1%
EBITDA-$7.09M74.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$19.89M-75.8%
Accounts Receivable$0.00M0.0%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.58M-43.1%
Short Term Debt$0.44M12.3%

Ratios

Q2 2025YOY Change
Return On Assets-81.54%-10.5%
Return On Invested Capital-73.32%-134.7%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$7.00M68.7%
Operating Free Cash Flow-$7.00M68.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.300.510.300.37-60.86%
Price to Tangible Book Value2.063.942.483.16-66.81%
Enterprise Value to EBITDA2.331.782.632.40-2342.02%
Return on Equity-102.9%-110.8%-110.7%-103.8%22.75%
Total Debt$1.31M$1.22M$1.12M$1.02M-27.72%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.